ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$0.39
+0.00 (+0.78%)
As of May 16, 2:37 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.01M
Net Income
-51,846,913
Gross Margin
77.6%
Profit Margin
-1,721.0%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 77.6% 47.7% 47.7% 47.7%
Operating Margin -2,874.5% 21.1% 17.6% 19.8%
Profit Margin -1,721.0% 12.8% 15.1% 11.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.01M 335.8K 347.3K 304.4K
Gross Profit 2.34M 160.1K 165.5K 145.1K
Operating Income -86,598,106 70.8K 61.3K 60.4K
Net Income -51,846,913 43.0K 52.4K 35.7K
Gross Margin 77.6% 47.7% 47.7% 47.7%
Operating Margin -2,874.5% 21.1% 17.6% 19.8%
Profit Margin -1,721.0% 12.8% 15.1% 11.7%
Rev Growth +0.6% +12.6% -7.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 556.4K 513.3K 557.3K
Total Equity 947.6K 993.8K 1.02M
D/E Ratio 0.59 0.52 0.55
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -40,810,202 73.2K 78.8K 66.7K
Free Cash Flow 45.7K 64.8K 36.1K